| WKN: | A0HG69 |
| ISIN: | GB00B0LCW083 |
| Land: | Großbritannien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Hikma Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 11. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2014 | 14,27 | 24,71 | 73,16% |
| 2 | 2010 | 5,51 | 9,21 | 67,15% |
| 3 | 2009 | 3,45 | 5,51 | 59,71% |
| 4 | 2013 | 9,08 | 14,27 | 57,16% |
| 5 | 2018 | 12,65 | 18,16 | 43,56% |
| 6 | 2019 | 18,16 | 23,42 | 28,96% |
| 7 | 2015 | 24,71 | 31,50 | 27,48% |
| 8 | 2012 | 7,37 | 9,08 | 23,20% |
| 9 | 2020 | 23,42 | 28,10 | 19,98% |
| 10 | 2007 | 5,26 | 6,23 | 18,44% |
| 11 | 2023 | 17,40 | 20,40 | 17,24% |
| 12 | 2024 | 20,40 | 23,80 | 16,67% |
| 13 | 2021 | 28,10 | 26,60 | -5,34% |
| 14 | 2011 | 9,21 | 7,37 | -19,98% |
| 15 | 2026 | 17,60 | 13,90 | -21,02% |
| 16 | 2025 | 23,80 | 17,60 | -26,05% |
| 17 | 2016 | 31,50 | 21,59 | -31,46% |
| 18 | 2022 | 26,60 | 17,40 | -34,59% |
| 19 | 2017 | 21,59 | 12,65 | -41,41% |
| 20 | 2008 | 6,23 | 3,45 | -44,62% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2008 | 6,23 | 3,45 | -44,62% |
| 2 | 2017 | 21,59 | 12,65 | -41,41% |
| 3 | 2022 | 26,60 | 17,40 | -34,59% |
| 4 | 2016 | 31,50 | 21,59 | -31,46% |
| 5 | 2025 | 23,80 | 17,60 | -26,05% |
| 6 | 2026 | 17,60 | 13,90 | -21,02% |
| 7 | 2011 | 9,21 | 7,37 | -19,98% |
| 8 | 2021 | 28,10 | 26,60 | -5,34% |
| 9 | 2024 | 20,40 | 23,80 | 16,67% |
| 10 | 2023 | 17,40 | 20,40 | 17,24% |
| 11 | 2007 | 5,26 | 6,23 | 18,44% |
| 12 | 2020 | 23,42 | 28,10 | 19,98% |
| 13 | 2012 | 7,37 | 9,08 | 23,20% |
| 14 | 2015 | 24,71 | 31,50 | 27,48% |
| 15 | 2019 | 18,16 | 23,42 | 28,96% |
| 16 | 2018 | 12,65 | 18,16 | 43,56% |
| 17 | 2013 | 9,08 | 14,27 | 57,16% |
| 18 | 2009 | 3,45 | 5,51 | 59,71% |
| 19 | 2010 | 5,51 | 9,21 | 67,15% |
| 20 | 2014 | 14,27 | 24,71 | 73,16% |